医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
ONC · BeOne Medicines Ltd.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
BeOne Medicines Ltd.（ONC）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $332.0M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-15。
买入 Bought—
卖出 Sold$332.0M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-13 | Wang Xiaodong Director, Other | 卖出 Sell | 31,027 | $350.99 | $10.9M | SEC |
| 2026-09-30 | Lee Chan Henry SVP, General Counsel | 卖出 Sell | 1,115 | $375.00 | $418K | SEC |
| 2026-09-28 | Wang Xiaodong Director, Other | 卖出 Sell | 31,028 | $364.79 | $11.3M | SEC |
| 2026-09-08 | Wang Xiaodong Director, Other | 卖出 Sell | 38,287 | $349.10 | $13.4M | SEC |
| 2026-09-01 | Ball Titus B. Principal Accounting Officer | 卖出 Sell | 132 | $355.86 | $47K | SEC |
| 2026-08-25 | Wu Xiaobin President and COO | 卖出 Sell | 280 | $380.00 | $106K | SEC |
| 2026-08-11 | Lee Chan Henry SVP, General Counsel | 卖出 Sell | 2,666 | $360.00 | $960K | SEC |
| 2026-08-10 | OYLER JOHN Chief Executive Officer, Director | 卖出 Sell | 240,810 | $359.12 | $86.5M | SEC |
| 2026-08-03 | Rosenberg Aaron Chief Financial Officer | 卖出 Sell | 1,157 | $312.71 | $362K | SEC |
| 2026-07-30 | Lee Chan Henry SVP, General Counsel | 卖出 Sell | 1,044 | $323.69 | $338K | SEC |
| 2026-07-22 | Lee Chan Henry SVP, General Counsel | 卖出 Sell | 1,669 | $325.00 | $542K | SEC |
| 2026-07-20 | OYLER JOHN Chief Executive Officer, Director | 卖出 Sell | 109,713 | $315.28 | $34.6M | SEC |
| 2026-07-15 | OYLER JOHN Chief Executive Officer, Director | 卖出 Sell | 283,154 | $315.56 | $89.4M | SEC |
| 2026-07-17 | OYLER JOHN Chief Executive Officer, Director | 卖出 Sell | 64,628 | $312.00 | $20.2M | SEC |
| 2026-07-10 | OYLER JOHN Chief Executive Officer, Director | 卖出 Sell | 60,218 | $303.18 | $18.3M | SEC |
| 2026-07-14 | OYLER JOHN Chief Executive Officer, Director | 卖出 Sell | 145,861 | $305.95 | $44.6M | SEC |
| 2026-07-08 | Lee Chan Henry SVP, General Counsel | 卖出 Sell | 664 | $302.46 | $201K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-30 | Lee Chan Henry Officer | 1,115 | $407K | 10b5-1 |
| 2026-09-08 | Wang Xiaodong Director, Chair, Scientific Advisory Brd | 131,370 | $47.1M | 10b5-1 |
| 2026-09-01 | Ball Titus B. Officer | 132 | $47K | |
| 2026-08-25 | Wu Xiaobin Officer | 15,000 | $5.6M | 10b5-1 |
| 2026-08-25 | Sanders Corazon (Corsee) D. Former Director | 2,075 | $788K | |
| 2026-08-11 | Lee Chan Henry Officer | 2,002 | $719K | 10b5-1 |
| 2026-08-10 | OYLER JOHN Director, Officer | 240,810 | $83.9M | 10b5-1 |
| 2026-08-03 | Rosenberg Aaron Officer | 1,157 | $362K | |
| 2026-07-30 | Lee Chan Henry Officer | 1,044 | $338K | |
| 2026-07-22 | Lee Chan Henry Officer | 2,001 | $638K | 10b5-1 |
内部人 Insiders
Wang Xiaodong、Lee Chan Henry、Ball Titus B.、Wu Xiaobin、OYLER JOHN、Rosenberg Aaron